Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02385266 · ClinicalTrials.gov registry record · Phase 4
Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain
A Phase 4 study, sponsored by Northwestern University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT02385266 is a Phase 4 study that was terminated before completion, run by Northwestern University. The registered enrollment target is 24 participants.
The verdict
NCT02385266, a Phase 4 study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of D-Cycloserine versus placebo treatment in reducing pain from urological chronic pelvic pain syndrome (UCPPS).
Interventions
- DRUG D-Cycloserine
- DRUG Placebo (for D-cycloserine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02385266
The ClinicalTrials.gov registry entry for NCT02385266 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which D-Cycloserine is the first listed.
NCT02385266 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02385266 about?
NCT02385266 is a clinical study titled "Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain". The purpose of this study is to evaluate the efficacy of D-Cycloserine versus placebo treatment in reducing pain from urological chronic pelvic pain syndrome (UCPPS).
What is the current status of trial NCT02385266?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2013-09. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02385266?
The interventions under investigation include: D-Cycloserine (DRUG), Placebo (for D-cycloserine) (DRUG).
Who is sponsoring clinical trial NCT02385266?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.